Biodol Therapeutics is a biotech company that provides compounds for treating chronic pain. Its technology platform is based on the use of receptor tyrosine kinase (RTK) FLT3 to develop small-molecule FLT3 inhibitors. In addition, this technology can be used to address the opioid crisis.